The experience of immunotherapy in lung cancer: an audit of immunotherapy use as second-line treatment for metastatic non-small cell lung cancer (NSCLC) in the South Tees region. (January 2019) - Hairudin, T.; Li, L.; Mansy, T.; Aynsley, E.; Kumar, G.; Masinghe, S.; Peedell, C.